Embla Medical hf (OCSE:EMBLA)
kr 35.3 0.8 (2.32%) Market Cap: 15.07 Bil Enterprise Value: 18.38 Bil PE Ratio: 31.89 PB Ratio: 2.86 GF Score: 71/100

Q2 2020 Ossur hf Earnings Call Transcript

Jul 23, 2020 / 07:00AM GMT
Release Date Price: kr44.3 (+0.23%)
Operator

Ladies and gentlemen, welcome to the Ãssur Q2 Results 2020. Today, I'm pleased to present Mr. Jón Sigurdsson, President and CEO.

(Operator Instructions) Speaker, please begin.

Jón Sigurdsson;ssur hf.;CEO;President
Ã

&

Yes. Thank you. I would like to welcome you to the Ãssur Investor Conference Call where we will cover the result for the second quarter of 2020. My name is Jón Sigurdsson, and I'm the President and CEO. And with me here today is Sveinn Sölvason, our CFO. We will begin by going through the highlights for the quarter and the financial results, after which a question-and-answer session will follow.

Financial performance has been significantly impacted by the COVID-19 pandemic. Sales were negatively impacted in many of Ãssur's main markets due to social distancing and other measures that were implemented by local authorities in relation to the COVID-19 pandemic. Sales in the second quarter of 2020, therefore, amounted to $135 million, which corresponds to a 25% organic decline

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot